Characteristics of apathy in treatment-naïve patients with Parkinson’s disease

References

• Yamawaki M, Kusumi M, Kowa H, et al. Changes in prevalence and incidence of Parkinson’s disease in Japan during a quarter of a century. Neuroepidemiology. 2009;32(4):263–269.
   PubMed Web of Science ®Google Scholar
• Khoo TK, Yarnall AJ, Duncan GW, et al. The spectrum of nonmotor symptoms in early Parkinson disease. Neurology. 2013;80(3):276–281.
   PubMed Web of Science ®Google Scholar
• Duncan GW, Khoo TK, Yarnall AJ, et al. Health-related quality of life in early Parkinson’s disease: the impact of nonmotor symptoms. Mov Disord. 2014;29(2):195–202.
   PubMed Web of Science ®Google Scholar
• Baig F, Lawton M, Rolinski M, et al. Delineating nonmotor symptoms in early Parkinson’s disease and first-degree relatives. Mov Disord. 2015;30(13):1759–1766.
   PubMed Web of Science ®Google Scholar
• Leentjens AF, Dujardin K, Marsh L, et al. Apathy and anhedonia rating scales in Parkinson’s disease: critique and recommendations. Mov Disord. 2008;23(14):2004–2014.
   PubMed Web of Science ®Google Scholar
• Pagonabarraga J, Kulisevsky J, Strafella AP, et al. Apathy in Parkinson’s disease: clinical features, neural substrates, diagnosis, and treatment. Lancet Neuro. 2015;14(5):518–531.
   PubMed Web of Science ®Google Scholar
• Santangelo G, Trojano L, Barone P, et al. Apathy in Parkinson’s disease: diagnosis, neuropsychological correlates, pathophysiology and treatment. Behav Neurol. 2013;27(4):501–513.
   PubMed Web of Science ®Google Scholar
• den Brok MG, van Dalen JW, van Gool WA, et al. Apathy in Parkinson’s disease: A systematic review and meta-analysis. Mov Disord. 2015;30(6):759–769.
   PubMed Web of Science ®Google Scholar
• Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson’s disease. J Neurol Neurosurg Psychiatry. 1988;51(6):745–752.
   PubMed Web of Science ®Google Scholar
• Starkstein SE, Mayberg HS, Preziosi TJ, et al. Reliability, validity, and clinical correlates of apathy in Parkinson’s disease. J Neuropsychiatry Clin Neurosci. 1992;4(2):134–139.
   PubMed Web of Science ®Google Scholar
• Okada K, Kobayashi S, Yamagata S, et al. Poststroke apathy and regional cerebral blood flow. Stroke. 1997;28(12):2437–2441.
   PubMed Web of Science ®Google Scholar
• Dubois B, Slachevsky A, Litvan I, et al. The FAB: a Frontal Assessment Battery at bedside. Neurology. 2000;55(11):1621–1626.
   PubMed Web of Science ®Google Scholar
• Wilson BA, Alderman N, Burgess PW, et al. Behavioural assessment of the dysexecutive syndrome. Bury St. Edmunds: Thames Valley Test Company; 1996.
   Google Scholar
• Kamei S, Hara M, Serizawa K, et al. Executive dysfunction using behavioral assessment of the dysexecutive syndrome in Parkinson’s disease. Mov Disord. 2008;23(4):566–573.
   PubMed Web of Science ®Google Scholar
• Visser M, Leentjens AF, Marinus J, et al. Reliability and validity of the Beck depression inventory in patients with Parkinson’s disease. Mov Disord. 2006;21(5):668–672.
   PubMed Web of Science ®Google Scholar
• Inoue T, Kitagawa M, Tanaka T, et al. Depression and major depressive disorder in patients with Parkinson’s disease. Mov Disord. 2010;25(1):44–49.
   PubMed Web of Science ®Google Scholar
• Saito S, Ayabe-Kanamura S, Takashima Y, et al. Development of a smell identification test using a novel stick-type odor presentation kit. Chem Senses. 2006;31(4):379–391.
   PubMed Web of Science ®Google Scholar
• Iijima M, Kobayakawa T, Saito S, et al. Smell identification in Japanese Parkinson’s disease patients: using the odor stick identification test for Japanese subjects. Intern Med. 2008;47(21):1887–1892.
   PubMed Web of Science ®Google Scholar
• Jankovic J, McDermott M, Carter J, et al. Variable expression of Parkinson’s disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group. Neurology. 1990;40(10):1529–1534.
   PubMed Web of Science ®Google Scholar
• Pedersen KF, Alves G, Brønnick K, et al. Apathy in drug-naïve patients with incident Parkinson’s disease: the Norwegian Park West study. J Neurol. 2010;257(2):217–223.
   PubMed Web of Science ®Google Scholar
• Dujardin K, Langlois C, Plomhause L, et al. Apathy in untreated early-stage Parkinson disease: relationship with other non-motor symptoms. Mov Disord. 2014;29(14):1796–1801.
   PubMed Web of Science ®Google Scholar
• Liu H, Ou R, Wei Q, et al. Apathy in drug-naïve patients with Parkinson’s disease. Parkinsonism Relat Disord. 2017;44:28–32.
   PubMed Web of Science ®Google Scholar
• Cubo E, Benito-León J, Coronell C, et al. ANIMO Study Group. Clinical correlates of apathy in patients recently diagnosed with Parkinson’s disease: the ANIMO study. Neuroepidemiology. 2012;38(1):48–55.
   PubMed Web of Science ®Google Scholar
• Reijnders JS, Ehrt U, Lousberg R, et al. The association between motor subtypes and psychopathology in Parkinson’s disease. Parkinsonism Relat Disord. 2009;15(5):379–382.
   PubMed Web of Science ®Google Scholar
• Hassan A, Vallabhajosula S, Zahodne LB, et al. Correlations of apathy and depression with postural instability in Parkinson disease. J Neurol Sci. 2014;338(1-2):162–165.
   PubMed Web of Science ®Google Scholar
• Hong JY, Sunwoo MK, Ham JH, et al. Apathy and olfactory dysfunction in early Parkinson’s disease. J Mov Disord. 2015;8(1):21–25.
   PubMed Web of Science ®Google Scholar
• Kalia LV, Lang AE. Parkinson’s disease. Lancet. 2015;386(9996);896–912.
   PubMed Web of Science ®Google Scholar
• Schwarz J, Odin P, Buhmann C, et al. Depression in Parkinson’s disease. J Neurol. 2011;258(suppl 2):S336–S338.
   PubMed Web of Science ®Google Scholar
• Aarsland D, Marsh L, Schrag A. Neuropsychiatric symptoms in Parkinson’s disease. Mov Disord. 2009;24(15):2175–2186.
   PubMed Web of Science ®Google Scholar
• Goetz CG, New developments in depression, anxiety, compulsiveness, and hallucinations in Parkinson’s disease. Mov Disord. 2010;25(suppl 1);S104–S109.
   PubMed Web of Science ®Google Scholar
• Dujardin K, Sockeel P, Delliaux M, et al. Apathy may herald cognitive decline and dementia in Parkinson’s disease. Mov Disord. 2009;24(16):2391–2397.
   PubMed Web of Science ®Google Scholar
• Alzahrani H, Venneri A. Cognitive and neuroanatomical correlates of neuropsychiatric symptoms in Parkinson’s disease: A systematic review. J Neurol Sci. 2015;356(1-2):32–44.
   PubMed Web of Science ®Google Scholar
• Santangelo G, Vitale C, Trojano L, et al. Relationship between apathy and cognitive dysfunctions in de novo untreated Parkinson’s disease: a prospective longitudinal study. Eur J Neurol. 2015;22(2):253–260.
   PubMed Web of Science ®Google Scholar
• Perfetti B, Varanese S, Mercuri P, et al. Behavioural assessment of dysexecutive syndrome in Parkinson’s disease without dementia: a comparison with other clinical executive tasks. Parkinsonism Relat Disord. 2010;16(1):46–50.
   PubMed Web of Science ®Google Scholar
• Starkstein SE. Apathy in Parkinson’s disease: diagnostic and etiological dilemmas. Mov Disord. 2012;27(2):174–178.
   PubMed Web of Science ®Google Scholar
• Santangelo G, Vitale C, Picillo M, et al. Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson’s disease patients. Parkinsonism Relat Disord. 2015;21(5):489–493.
   PubMed Web of Science ®Google Scholar
• Litvan I, Goldman JG, Tröster AI, et al. Diagnostic criteria for mild cognitive impairment in Parkinson’s disease: Movement Disorder Society Task Force guidelines. Mov Disord. 2012;27(3):349–356.
   PubMed Web of Science ®Google Scholar
• Burn DJ, Landau S, Hindle JV, et al.; PROMS-PD Study Group. Parkinson’s disease motor subtypes and mood. Mov Disord. 2012;27(3):379–386.
   PubMed Web of Science ®Google Scholar
• Ng A, Chander RJ, Tan LC, et al. Influence of depression in mild Parkinson’s disease on longitudinal motor and cognitive function. Parkinsonism Relat Disord. 2015;21(9):1056–1060.
   PubMed Web of Science ®Google Scholar